Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting

QJM: An International Journal of Medicine

Volumn 101, Issue 9, 2008, Pages 749-751

  Manzano Fernández, Sergio ^a   Marin, Francisco ^a   Martinez, Jose A Hurtado ^a   Cambronero, Francisco ^a   Valdés, Mariano ^a   Ruiz Nodar, Juan Miguel ^b   Pérez Berbel, Patricio ^b   Lip, Gregory Y H ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN;

AGE DISTRIBUTION; AGED; ANEMIA; BLEEDING; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; DRUG INDICATION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SPAIN;

EID: 51049103189     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn082     Document Type: Letter

References (5)

1. Foley P, Foley S, Kinnaird T, Anderson RA. Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: A deadly combination. Q J Med 2008; 101:425-33.
2. Manzano-Fernández S, Pastor FJ, Marin F, Cambronero F, Caro C, Pascual-Figal DA, et al. Increased major bleeding complications related to triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008 (in press).
3. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, et al Impact of anaemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Invesiipation to Lower Late Angiopiasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44 547-53.
4. World Health Organization. Nutritional Anemias: Report of a WHO Scientific Group. Geneva, World Health Organization, 1968.
5. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338:1488-97.